144 related articles for article (PubMed ID: 25419367)
1. A chronic obstructive pulmonary disease negatively influences the prognosis of patients with bladder urothelial carcinoma via hypoxia inducible factor-1α.
Huang Z; Xu R; Lv C; Zhong Z; Zhang L; Zhu L; Tang Y; Zhao X
Int J Clin Exp Med; 2014; 7(10):3344-53. PubMed ID: 25419367
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of hypoxia inducible factor-1α expression in patients with clear cell renal cell carcinoma.
Wu S; Jiang F; Wu H; Wang Y; Xu R; Cao J; Lu Q; Zhu X; Zhong Z; Zhao X
Mol Med Rep; 2018 Mar; 17(3):4846-4852. PubMed ID: 29328439
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia inducible factor-1alpha and microvessel density as angiogenic factors in bilharzial and non-bilharzial bladder cancer.
Badr S; Salem A; Yuosif AH; Awadallah H; Awed N; Bakr A
Clin Lab; 2013; 59(7-8):805-12. PubMed ID: 24133909
[TBL] [Abstract][Full Text] [Related]
6. The association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: A case-control study.
Yu ZG; Wang BZ; Cheng ZZ
Kaohsiung J Med Sci; 2017 Sep; 33(9):433-441. PubMed ID: 28865600
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of hypoxia-inducible factor-1α in patients with chronic obstructive pulmonary disease and smokers with normal lung function].
Tao H; Luo W; Pei H; Zhu S; Zhang M; Chen B; He J; Zhang M; Zhou R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):852-5. PubMed ID: 25108440
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma.
Huang C; Huang Z; Zhao X; Wang Y; Zhao H; Zhong Z; Wang L
Onco Targets Ther; 2018; 11():2111-2120. PubMed ID: 29695918
[TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma.
Kim JI; Choi KU; Lee IS; Choi YJ; Kim WT; Shin DH; Kim K; Lee JH; Kim JY; Sol MY
Oncol Lett; 2015 Apr; 9(4):1699-1706. PubMed ID: 25789026
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in patients with bone tumor: a systematic review and meta-analysis.
Luo D; Ren H; Zhang W; Xian H; Lian K; Liu H
J Orthop Surg Res; 2019 Feb; 14(1):56. PubMed ID: 30782196
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Gruber G; Greiner RH; Hlushchuk R; Aebersold DM; Altermatt HJ; Berclaz G; Djonov V
Breast Cancer Res; 2004; 6(3):R191-8. PubMed ID: 15084243
[TBL] [Abstract][Full Text] [Related]
13. [Expression of hypoxia-inducible factor 1α in gastric cancer and its clinical signficance].
Wu YL; Hu LN; Zheng CD; Sun RC; Zhang SX; Yan Q; Li YX
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1418-23. PubMed ID: 27266349
[TBL] [Abstract][Full Text] [Related]
14. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
Li JN; Feng ZE; Wang L; Wang YX; Guo CB
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
[TBL] [Abstract][Full Text] [Related]
16. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
[TBL] [Abstract][Full Text] [Related]
17. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the VHL, HIF-1α, and VEGF Signaling Pathway and Associated MAPK (ERK1/2 and ERK5) Pathways in Clear-Cell Renal Cell Carcinoma. A Long-Term Study.
Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SY; Roche-Losada O; Sánchez-Prieto R; Giménez-Bachs JM
Clin Genitourin Cancer; 2017 Dec; 15(6):e923-e933. PubMed ID: 28624320
[TBL] [Abstract][Full Text] [Related]
19. [Expression of mitogen-actived protein kinase, phosphatidylinositol 3-kinase and hypoxia-inducible factor-1alpha in pulmonary arteries of patients with chronic obstructive pulmonary disease].
Kong CC; Dai AG
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):372-5. PubMed ID: 17045016
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
